A Distinguished Professor of Epidemiology and Medicine, this appointment will support Dr. Newman in her role as Clinical Director of the Aging Institute where she is engaged early stage clinical trials that address the biology of aging.

We are pleased to announce the appointment of Anne Newman, MD, MPH, as the UPMC Chair in Geroscience in the School of Medicine effective September 1, 2022.

A recognized population health scientist, Dr. Newman’s work has addressed the antecedents of functional decline in old age. As principal investigator of several major cohorts studies in Pittsburgh, she has studied thousands of older adults, making important observations on the causes and consequences of functional decline. She has conducted several large trials testing lifestyle and medications to improve health span. More recently, her work has shifted to identify the predictors of healthy aging include genetics and metabolomic signatures that might be incorporated into biomarker tools to assess as intermediate markers for interventions on aging. She has published over 800 papers in the top journals in her field and has been cited by Thompson-Reuters as one of the most highly cited scientists in the world with a h-index of 169 overall and 107 in the past 5 years. She is a member of the Association of American Physicians (AAP) and the American Epidemiology Society (AES). She is a frequent advisor to the National Institute on Aging, currently serving on the Board of Scientific Counselors of the National Institute on Aging (NIA), with past service on the National Advisory Council on Aging. She serves on several review panels, workshops and monitoring boards, including the recent Geroscience Summit at NIA where she addressed clinical trial outcomes.

A Distinguished Professor of Epidemiology, Professor of Medicine and Clinical and Translational Science and the Clinical Director of the Aging Institute at the University of Pittsburgh and UPMC, is a renowned international expert in the epidemiology of aging and longevity. Having earned her MD/MPH degree from the University of Pittsburgh, Dr. Newman is a board-certified geriatrician and completed her training at Presbyterian University Hospital. She joined the faculty at the University of Pittsburgh in 1987 in the Division of Geriatric Medicine, Department of Medicine with a joint appointment in the Graduate School of Public Health as Associate Professor of Epidemiology following in 1998. In 2010, Dr. Newman was appointed as Chair, Department of Epidemiology and in 2014 as the Katherine M. Detre Endowed Chair of Population Health Science in the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh. Dr. Newman recently stepped down from these roles to focus on her role as Clinical Director of the Aging Institute, continuing as Distinguished Professor of Epidemiology.

The UPMC Chair in Geroscience will support Dr. Newman in her role as Clinical Director of the Aging Institute. She plans to extend her intervention work to early-stage clinical trials that address the biology of aging. Recruitment is planned to begin this fall in the RIGHT study, Reducing Inflammation for Geriatric Healthspan Therapy.